Yanina Grant-huerta
Chief Accounting Officer at Atara Biotherapeutics, Inc. (ATRA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $57K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 20SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 2,41449,636 held (−5%) | $9.13 | $22K | +3.8% |
| Mar 4SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 2433,830 held (−0%) | $5.08 | $122 | +86.6% |
| Mar 4SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 1,60332,227 held (−5%) | $5.08 | $8K | +86.6% |
| Mar 4SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 37731,850 held (−1%) | $5.08 | $2K | +86.6% |
| Mar 4SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 10031,750 held (−0%) | $5.08 | $508 | +86.6% |
| Nov 19SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 1,64533,613 held (−5%) | $13.19 | $22K | -28.1% |
| Nov 19SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 8533,528 held (−0%) | $13.19 | $1K | -28.1% |
| Nov 19SEC | ATRAAtara Biotherapeutics, Inc. | Sell | 7433,454 held (−0%) | $13.19 | $976 | -28.1% |